Bleeding after oral soft tissue biopsy in people taking DOAC blood thinners
Official title: Bleeding Outcomes Following Oral Soft Tissue Biopsy in Patients Receiving Direct Oral Anticoagulants
Run by University of Pisa · NCT07520890 · Data updated 2026-11-12
This study will test whether continuing DOAC blood thinners is safe for people having an excisional oral soft tissue biopsy by comparing bleeding in 50 patients on uninterrupted DOACs with 50 patients not on anticoagulants.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Pisa Academic / other |
| Locations | 1 site (Pisa, Pi) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | May 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT07520890 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who need an excisional oral soft tissue biopsy, can provide informed consent, and either are taking a DOAC or are not on anticoagulants, without congenital or acquired coagulopathy and not on active antiplatelet therapy other than low‑dose aspirin.
✕Probably not a fit
Patients with known bleeding disorders, active non‑aspirin antiplatelet therapy, severe liver disease, or who require different or more extensive oral procedures may not benefit from the study's findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective case-control study at the Unit of Dentistry and Oral Surgery, University Hospital of Pisa, compares bleeding outcomes in 50 patients who continue DOAC therapy and 50 anticoagulant‑naive controls undergoing a standardized excisional oral soft tissue biopsy under local anesthesia with resorbable sutures. Bleeding will be recorded intraoperatively, at set perioperative timepoints up to 80 minutes, and by patient diary from postoperative days 1 through 7. Local haemostatic measures (tranexamic acid‑soaked gauze, resuturing, diathermocoagulation) will be applied as needed and DOACs will not be interrupted. The study aims to clarify whether continuing DOACs is safe for this specific oral surgical procedure.
Why it matters
Potential benefit: If successful, patients on DOACs may be able to continue their anticoagulant therapy for oral soft tissue biopsies, avoiding interruption and reducing thromboembolic risk while maintaining manageable bleeding control.
How similar studies have gone: Existing evidence on DOAC management for oral soft tissue biopsy is limited and mixed, so this prospective standardized comparison is relatively novel for this procedure.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * capacity to understand and sign informed consent; * documented indication for oral soft tissue biopsy Exclusion Criteria: * inability to provide consent; * congenital or acquired coagulopathy (including haemophilia, von Willebrand disease, thrombocytopenia, or hepatic cirrhosis); * active antiplatelet therapy other than low-dose aspirin
Where it's running
-
University of Pisa
Pisa, Pi, Italy Recruiting
Study contacts
- Study coordinator: Marco Nisi, Prof.
- Email: marco.nisi@unipi.it
- Phone: 050993193
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Apixaban to help arm fistulas mature in people with end-stage kidney disease
This trial will try a short course of apixaban in adults with end-stage kidney disease getting a new arm arteriovenous fistula to see if it helps the fistula mature for hemodialysis.
-
Augmented reality glasses or noise-cancelling headphones to reduce anxiety during dental procedures
This trial will test whether AR glasses or noise-cancelling headphones with relaxing music can help adults feel less anxious during routine dental and minor oral surgical procedures.
-
Timing of hip fracture surgery for patients on DOAC blood thinners
This project will see if operating within 24 hours is as safe as delaying surgery for people with hip fractures who recently took DOAC blood thinners by comparing how often they need blood transfusions.
-
Bone substitutes with NIPSA for intrabony periodontal defects
This study tests two bone substitutes (GTO and GenOs) used with the NIPSA technique to see which supports better gum and bone healing in adults with Stage III periodontitis.
-
Renal perfusion during minimally invasive abdominal surgery using ultrasound and NIRS
Researchers will test if Doppler ultrasound RRI and NIRS-based rSO₂ can detect changes in kidney perfusion during elective laparoscopic surgery in adults with varying health status.
-
Comparing postoperative pain after robotic versus laparoscopic colorectal surgery
We will test whether robotic surgery causes less pain than laparoscopic surgery for adults having elective colon (right or left hemicolectomy) operations who meet the hospital's enhanced recovery (RICA) protocol.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.